Wang B - Search Results

1

Generation, secretion and degradation of cancer immunotherapy target PD-L1.

Shen DD, Bi YP, Pang JR, Zhao LJ, Zhao LF, Gao Y, Wang B, Liu HM, Liu Y, Wang N, Zheng YC, Liu HM. Shen DD, et al. Among authors: wang n, wang b. Cell Mol Life Sci. 2022 Jul 11;79(8):413. doi: 10.1007/s00018-022-04431-x. Cell Mol Life Sci. 2022. PMID: 35819633 Review.

2

Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.

Zhao TQ, Zhao YD, Liu XY, Wang B, Li ZH, He ZX, Zhang XH, Liang JJ, Ma LY, Liu HM. Zhao TQ, et al. Among authors: wang b. Eur J Med Chem. 2018 May 10;151:327-338. doi: 10.1016/j.ejmech.2018.03.084. Epub 2018 Apr 3. Eur J Med Chem. 2018. PMID: 29635165

3

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.

Wang B, Ma LY, Wang JQ, Lei ZN, Gupta P, Zhao YD, Li ZH, Liu Y, Zhang XH, Li YN, Zhao B, Chen ZS, Liu HM. Wang B, et al. Among authors: wang jq. J Med Chem. 2018 Jul 26;61(14):5988-6001. doi: 10.1021/acs.jmedchem.8b00335. Epub 2018 Jul 18. J Med Chem. 2018. PMID: 29975529

4

Thiosemicarbazone-based selective proliferation inactivators inhibit gastric cancer cell growth, invasion, and migration.

Hu B, Wang B, Zhao B, Guo Q, Li ZH, Zhang XH, Liu GY, Liu Y, Tang Y, Luo F, Du Y, Chen YX, Ma LY, Liu HM. Hu B, et al. Among authors: wang b. Medchemcomm. 2017 Oct 23;8(12):2173-2180. doi: 10.1039/c7md00353f. eCollection 2017 Dec 1. Medchemcomm. 2017. PMID: 30108734 Free PMC article.

5

An overview on the methods of determining the activity of Indoleamine 2, 3-Dioxygenase 1.

Zhao Y, Wang B, Liu J, Sun P, Liu H. Zhao Y, et al. Among authors: wang b. J Drug Target. 2019 Aug;27(7):724-731. doi: 10.1080/1061186X.2018.1523416. Epub 2018 Dec 5. J Drug Target. 2019. PMID: 30215536 Review.

6

Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.

Zhao TQ, Zhao YD, Liu XY, Li ZH, Wang B, Zhang XH, Cao YQ, Ma LY, Liu HM. Zhao TQ, et al. Among authors: wang b. Eur J Med Chem. 2019 Jan 1;161:493-505. doi: 10.1016/j.ejmech.2018.10.058. Epub 2018 Oct 25. Eur J Med Chem. 2019. PMID: 30388465

7

IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.

Li J, Shen D, Tang J, Wang Y, Wang B, Xiao Y, Cao C, Shi X, Liu HM, Zhao W, Zhang J. Li J, et al. Among authors: wang y, wang b. Eur J Pharmacol. 2019 Jul 5;854:307-319. doi: 10.1016/j.ejphar.2019.04.046. Epub 2019 Apr 27. Eur J Pharmacol. 2019. PMID: 31039343

8

Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.

Wang JQ, Wang B, Lei ZN, Teng QX, Li JY, Zhang W, Ji N, Cai CY, Ma LY, Liu HM, Chen ZS. Wang JQ, et al. Among authors: wang b. Eur J Pharmacol. 2019 Nov 15;863:172611. doi: 10.1016/j.ejphar.2019.172611. Epub 2019 Aug 30. Eur J Pharmacol. 2019. PMID: 31476282

9

Gramine-based structure optimization to enhance anti-gastric cancer activity.

Zhang XH, Guo Q, Wang HY, Li YH, Khamis MY, Ma LY, Wang B, Liu HM. Zhang XH, et al. Among authors: wang hy, wang b. Bioorg Chem. 2021 Feb;107:104549. doi: 10.1016/j.bioorg.2020.104549. Epub 2020 Dec 10. Bioorg Chem. 2021. PMID: 33383324

10

Targeting neddylation E2s: a novel therapeutic strategy in cancer.

Zheng YC, Guo YJ, Wang B, Wang C, Mamun MAA, Gao Y, Liu HM. Zheng YC, et al. Among authors: wang c, wang b. J Hematol Oncol. 2021 Apr 7;14(1):57. doi: 10.1186/s13045-021-01070-w. J Hematol Oncol. 2021. PMID: 33827629 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44,118 results

Search Page